Will Buffet, Bezos, and Dimon be able to control health care costs?

Three of the most famous names in American business walked into a health care problem…and the problem didn’t even flinch.
When Warren Buffett, Jeff Bezos, and Jamie Dimon teamed up to take on U.S. health care costs, it sounded like the start of a superhero movie:
limitless resources, elite talent, and enough negotiating power to make anyone at a hospital billing office break into a nervous sweat.

But health care isn’t like buying paper towels in bulk. It’s a maze of local monopolies, opaque prices, complex incentives, and rules that vary by state,
plan, employer, and sometimes the mood of a claims processor on a Monday morning. So the real question isn’t whether these leaders are smart enough
(they clearly are). It’s whether the tools available to employerseven gigantic onesare strong enough to bend a system where prices are often set
by market power, not by “best deal” logic.

Let’s dig into what they tried, what went wrong, what’s changed since, and what a realistic “yes” would actually look like.

Why this question became famous (and why it still matters)

In 2018, the business world buzzed about a new employer-led health care venture. The basic pitch: if big companies pay a huge share of America’s medical bills
through employer-sponsored insurance, maybe big companies can also fix what’s brokenrising premiums, confusing benefits, surprise bills, and inconsistent quality.

For employers, the motivation is painfully practical. Health benefits aren’t a nice little perk anymore; they’re a second payroll system that grows faster than wages.
Even when employees “have insurance,” they may still avoid care because deductibles and copays bite like a tax on being human.

The “Haven” era: big hype, small leverage

The Buffett–Bezos–Dimon collaboration created a venture (later named “Haven”) meant to improve the employee health care experience and lower costs.
Investors and incumbents panickedbecause if anyone could untangle U.S. health care, surely it would be a trio of corporate giants.

Then reality arrived, uninvited, like a hospital facility fee.

Haven ultimately shut down in early 2021. That outcome didn’t prove the leaders were wrong to try; it proved the system is harder to move than people assumed.
Haven reportedly explored multiple approachesbetter primary care, improved care navigation, employer purchasing strategiesbut the venture struggled to turn
experiments into broad, scalable savings across different geographies, provider markets, and employee needs.

Think of it this way: an employer can redesign benefits and nudge behavior, but it can’t easily change what a dominant hospital system charges in a region where
patients have limited alternatives. You can threaten to walk away, but if the hospital is “the” hospital, the threat is mostly theatrical.

What actually drives U.S. health care costs (spoiler: it’s not “too many doctor visits”)

The U.S. spends more per person on health care than other wealthy countries, and it’s not because Americans are constantly joyriding in ambulances.
A large body of research and cross-country comparisons consistently points to higher pricesfor hospital care, physician services, procedures, and drugs
as a major reason costs are so high.

Four cost drivers that don’t care how famous you are

1. High pricesespecially hospital prices.
   In many markets, large health systems have enough leverage to demand higher commercial rates. Even “routine” care can carry premium pricing when competition is thin.
2. Consolidation and market power.
   When hospitals buy physician groups (or when insurers and middlemen vertically integrate), negotiations often tilt away from employers and patients.
   Fewer competitors usually means less pressure to keep prices reasonable.
3. Administrative complexity.
   U.S. health care has layers of billing codes, contracting structures, utilization management, and benefits rulescostly “paperwork economics” that don’t heal anyone.
4. Pharmacy and specialty drug spending.
   Breakthrough drugs can be life-changingand budget-breaking. Employers are increasingly focused on high-cost categories, including specialty medications
   and newer weight-loss drugs that can substantially affect premiums.

Here’s the uncomfortable truth: if your problem is “prices are high because the most powerful local providers can make them high,” then even very large employers
often end up negotiating around the edgescopays, deductibles, networks, and vendorsrather than resetting the price baseline itself.

So…can they control costs? Depends what “control” means

If “control” means making U.S. health care cheap nationwide, that’s mostly a policy-level outcome involving competition, regulation, and payment reform.
Employer innovation alone rarely changes the national price trajectory.

If “control” means reducing trend for their own employees and proving models others can copy, then yesat least partially.
The realistic ceiling is “meaningful improvements” rather than “total domination.”

What big employers can do (and what they can’t)

Employers have three main levers: how care is purchased, how employees are guided to care, and how financial incentives are set.
But they have limited ability to force broad price reductions in highly consolidated markets.

The employer playbook: where savings actually come from

The most successful employer strategies tend to focus on specific “pressure points,” not abstract reform. Here are approaches that show up repeatedly because,
unlike motivational posters, they sometimes work.

1) Make primary care the front door (and actually staff it)

Strong primary care can reduce avoidable ER visits, improve chronic disease management, and catch problems earlierwhen they’re cheaper to treat.
Employers try this through advanced primary care clinics, direct primary care arrangements, or membership-style models.

The catch: primary care helps most when it’s connected to the rest of the systemspecialists, hospitals, behavioral health, and pharmacy.
Otherwise, it becomes a “nice experience” that doesn’t fully change downstream costs.

2) Steer employees to high-value care (without starting a workplace rebellion)

Many employers use “centers of excellence” for surgeries and complex caredesignating high-quality providers and offering incentives to use them.
Some use reference pricing (the plan pays up to a set amount), narrow networks, or tiered networks.

Savings can be real, but employee trust is fragile. If you remove a beloved local hospital from the network, you’d better have a clear story and a better option
because “we did it for the actuarial spreadsheet” is not a crowd-pleaser.

3) Attack high-cost claims with better navigation

A small portion of members typically account for a large portion of spendingthink complex cancer care, high-risk pregnancies, severe chronic illness,
or multiple comorbidities. Employers increasingly invest in care navigation, case management, and second-opinion programs to reduce waste, duplication,
and avoidable complications.

4) Get serious about pharmacy spending

Drug costs aren’t just a line item; they’re a strategy battleground. Employers evaluate pharmacy benefit management arrangements, specialty pharmacy,
formulary strategy, prior authorization policies, andmore recentlycoverage rules for expensive drug classes that can move premiums.

The best pharmacy strategies don’t just “deny.” They balance access, clinical appropriateness, and long-term value. (Because a short-term savings win that causes
long-term complications is the financial equivalent of turning off your smoke alarm to save electricity.)

What’s different now: the “post-Haven” world

Even though the original high-profile joint venture ended, the underlying idealarge employers using scale, data, and consumer experience to improve care and costs
didn’t disappear. It just changed shape.

Amazon’s evolving strategy: primary care + pharmacy + consumer convenience

Amazon continued building health care capabilities through primary care (including One Medical), pharmacy, and virtual care options.
The company’s approach looks less like “one grand joint venture” and more like a modular toolkit: easier access, simpler digital workflows,
and targeted services that can plug into employer benefits.

This strategy makes sense because it aims at two chronic U.S. health care weaknesses: access friction (it’s hard to get timely care)
and opaque, inconsistent pricing (nobody knows what anything costs until after it happens).
Convenient care can reduce waste, but it won’t automatically reduce hospital pricesthe biggest beast in the cost jungle.

JPMorgan’s angle: sophisticated purchasing and benefits management

Large employers like JPMorgan have the scale to experiment with alternative payment models, direct provider contracting, and specialized vendor ecosystems.
They can use data analytics to identify cost spikes, regional price outliers, and opportunities for smarter networks.

The limitation is structural: even a massive employer is often negotiating against local health systems that are bigger (in health care terms) than any single company’s footprint.

Berkshire Hathaway’s angle: patience, insurance knowledge, and decentralized reality

Berkshire’s world is famously decentralized, which is both a strength and a headache. The strength: flexibility and long-term thinking.
The headache: standardizing health benefits strategies across diverse subsidiaries is like herding cats…who all have different HR departments.

Still, Berkshire’s broader experience in insurance and risk economics provides a clear-eyed view of what cost control really means:
reducing unnecessary utilization is helpful, but changing price dynamics is where the big savings live.

Why controlling costs is so hard (even for billionaires)

Let’s name the villainsnot cartoon villains, but systemic villains that show up in plan renewals and CFO meetings.

1) Local provider market power beats national employer power

Health care is local. Employers are national. A hospital system that dominates a metro area can often demand higher rates because
patients and doctors have limited alternatives. Employers can negotiate, but “take it or leave it” is tough when “leave it” means no major hospital in town.

2) Employees are not identical shoppers

In retail, consumer choice is a feature. In health care, consumer choice is complicated by urgency, provider referrals, and imperfect information.
Employers can “steer,” but they can’t treat employees like price-optimization robots. People choose based on trust, relationships, convenience, and fearoften rationally.

3) Savings often require behavior change, and behavior change is…human

The best-designed plan fails if people don’t understand it, don’t trust it, or don’t have time to use it. Navigation tools, telehealth,
and primary care membership models helpwhen they’re simple and when access is real.

4) The system is full of “middle layers”

Between employers and providers sit insurers, networks, PBMs, brokers, third-party administrators, and specialty vendors.
Some add value, some add cost, and many add complexity. Employers trying to “control costs” often discover they’re also trying to control a supply chain of contracts.

A realistic forecast: what success would look like

If you’re expecting a single trio of business leaders to permanently “control” U.S. health care costs, you’ll probably be disappointed.
But if you define success as measurable savings for their covered populations, better patient experience,
and scalable employer strategies that spread, then progress is plausible.

“Best case” outcomes (practical, not magical)

• Slower premium growth for employees through tighter purchasing, better networks, and smarter pharmacy management.
• Lower out-of-pocket surprises by improving transparency, navigation, and plan design.
• Better primary care access that reduces downstream complications and improves chronic condition control.
• Stronger accountability from vendors and provider systems through data, contracting innovation, and performance incentives.

“Not likely without broader reform” outcomes

• Nationwide hospital price resets in highly consolidated markets.
• Uniform transparency and competition across all regions and specialties.
• System-wide administrative simplification without multi-payer and regulatory alignment.

What would increase the odds of real cost control?

If the goal is meaningful, sustained cost controlnot just shifting costs aroundthen employer innovation works best when it aligns with broader forces.

Price transparency that actually changes decisions

Transparency is only useful when prices are comparable, accessible, and tied to incentives.
If employees can see real prices and keep more money by choosing high-value options, market pressure strengthens.

More competition (or more enforcement) in provider markets

When a region has one dominant health system, “shopping” is mostly theoretical. Stronger antitrust scrutiny and market oversight can matter here,
especially for mergers and vertical integration that increase leverage.

Payment models that reward outcomes, not volume

Value-based care is not a magic spell, but it’s one of the few frameworks designed to realign incentives.
When done well, it can reduce avoidable admissions and improve chronic care. When done poorly, it becomes a new layer of paperwork wearing a “value” costume.

Experiences from the real world: what employers and employees have lived through (about )

If you want to understand whether business leaders can control health care costs, don’t start with press releasesstart with the lived experiences
of people who have tried to make the math work.

Experience #1: The benefits manager who discovered “cheaper” isn’t always cheaper.
A large employer introduces a narrower network with lower premiums. On paper, the savings look great. In reality, employees complain that their longtime doctor
is out of network, and the closest in-network specialist has a six-week wait. Some employees delay care; others go out of network anyway and get hit with bigger bills.
Eventually, the employer learns a tough lesson: cost control requires access. If you don’t pair network changes with better appointment availability,
navigation support, and clear communication, you don’t get savingsyou get frustration (and sometimes worse health outcomes).

Experience #2: The employee with a “good plan” who still avoids care.
Many workers technically have coverage, yet a high deductible makes routine care feel expensive. One employee skips physical therapy after an injury
because the copays stack up. Months later, the problem worsens and becomes a more expensive episode of care. Employers see this pattern repeatedly:
cost-sharing can reduce utilization, but it can also reduce the right utilization. That’s why many modern benefit designs try to make high-value services
(like certain preventive care, chronic disease management, or primary care visits) easier to access while discouraging wasteful spending elsewhere.

Experience #3: The “primary care upgrade” that employees actually use.
In another company, leadership invests in a primary care model with better scheduling, virtual options, and proactive outreach.
Employees can book same- or next-day visits, get quick answers for minor conditions, and receive follow-ups for chronic issues like hypertension or diabetes.
Over time, the employer sees fewer avoidable ER claims and fewer duplicated tests. The lesson: the most effective cost-control moves often feel like
service improvements, not restrictions. People engage when care is convenient, responsive, and human.

Experience #4: The pharmacy “surprise” that blows up the budget.
A company renews its plan expecting normal trend, then a wave of high-cost prescriptions arrivesspecialty drugs, complex therapies, and newer weight-loss medications.
The employer doesn’t want to be the villain denying care, but it also can’t accept an unlimited blank check. It experiments with prior authorization rules,
clinical criteria, step therapy, and careful coverage policieswhile improving coaching and support so employees aren’t left alone to figure out alternatives.
The takeaway: pharmacy is where science meets finance, and the only sustainable approach combines clinical rigor with compassion.

Experience #5: The “direct-to-provider” deal that works…until it hits geography.
Some employers try direct contracts with high-value providers or create centers of excellence for certain surgeries.
The approach can yield real savings and better outcomesespecially for planned procedures like joint replacements.
But it’s harder to scale for urgent, local needs (like emergency care) or in regions with limited provider choice.
In other words, the strategy works best as part of a portfolio, not as a universal fix.

Put these experiences together and a clear pattern emerges: business leaders can influence costs when they improve access,
simplify choices, steer toward value, and negotiate smarter. But they can’t fully “control” costs without confronting the
structural driversespecially provider market power and high unit prices.

Final take

Buffett, Bezos, and Dimon can’t wave a wand and make American health care affordable for everyone. But they can help build models that reduce friction,
improve primary care access, apply smarter purchasing pressure, and tame certain cost driversespecially for the populations their companies cover.
The biggest wins are likely to look less like a dramatic “disruption” and more like a steady, unglamorous reshaping of how care is accessed, purchased, and managed.